'Huge therapeutic potential': University of Sask. researchers make progress on stroke treament
A drug typically used to treat schizophrenia is showing positive signs during early stages of research, bringing down stroke-related swelling in the brain.
The research is being conducted by the researchers from the University of Saskatchewan, Columbia University, and the University of Oxford with help from the Canadian Light Source involves a drug called trifluoperazine (TFP).
TFP is already approved for human use and researchers believe it has the potential to stop swelling in the brain that occurs after a stroke or cerebral injury.
According to a release from the CLS, TFP acts on “doughnut-shaped” water channel proteins called aquaporins, which are in brain cells.
During a stroke, the blood supply to the brain is restricted and prevents cells from receiving enough oxygen, which leads to swelling in the brain as oxygen-starved cells cannot do their usual job of maintaining a balance of fluid, nutrients, and electrolytes.
“Water rushes from the outside through these doughnut-shaped proteins, into the cells that then swell. The build-up of pressure damages the fragile brain tissue, disturbing the flow of electrical signals from the brain to the body,” Dr. Mootaz Salman, Research Scientist in the Department of Physiology, Anatomy, and Genetics at the University of Oxford and the corresponding author on this studysaid in a release.
“Edema, which is swelling due to water or other body fluid accumulation, is the hallmark of stroke and plays a major role in stroke-associated morbidity and mortality.”
The idea is that TFP stops all of this from happening by preventing a signal that would normally cause more aquaporin channels to rise to the surface of brain cells.
“Our novel approach offers new hope for patients with central nervous system injuries and strokes and has a huge therapeutic potential,” Dr. Salman said in the release.
“These findings suggest it could be a good candidate for early phase of human clinical application at a low treatment cost in the near future.”
Dr. Patrice Lindsay, Director of Health Systems Change at the Heart and Stroke Foundation said that any research done to further the medical communities knowledge on strokes is crucial.
“Any new research that’s coming out that shows promise at reducing the impact of stroke, reducing the damage that could be caused, is very exciting, and things we will be watching very closely. We need more research like this,” Dr. Lindsay said.
Dr. Lindsay said international partnerships are important for the field, combining expertise and resources goes a long way to further the study as a community.
“We’re encouraging those international partnerships. Rather than duplicating each other’s work, to work together and leverage, and you can get so much further ahead so much faster. These partnerships are so exciting and a great example for others to follow,” Dr. Lindsay said.
As TFP is already approved for human use, Dr. Lindsay said the process to vigorously test the drug will be a bit quicker, meaning it could potentially be helping patients sooner than if it was a brand new drug.
“We will continue to monitor very closely as this research evolves. When the evidence is substantial enough we can try to quickly move it into practice so it can help as many patients as possible,” Dr. Lindsay told CTV.
CTVNews.ca Top Stories
BREAKING Iran fires air defence batteries in provinces as sound of explosions heard near Isfahan
Iran fired air defence batteries early Friday morning after reports of explosions near the city of Isfahan, the state-run IRNA news agency reported.
American millionaire Jonathan Lehrer denied bail after being charged with killing Canadian couple
American millionaire Jonathan Lehrer, one of two men charged in the killings of a Canadian couple in Dominica, has been denied bail.
Nearly half of China's major cities are sinking, researchers say
Nearly half of China's major cities are suffering 'moderate to severe' levels of subsidence, putting millions at risk of flooding especially as sea levels rise.
Prince Harry formally confirms he is now a U.S. resident
Prince Harry, the son of King Charles III and fifth in line to the British throne, has formally confirmed he is now a U.S. resident.
Judge says 'no evidence fully supports' murder case against Umar Zameer as jury starts deliberations
The judge presiding over the trial of a man accused of fatally running over a Toronto police officer is telling jurors the possible verdicts they may reach based on the evidence in the case.
Health Canada to change sperm donor screening rules for men who have sex with men
Health Canada will change its longstanding policy restricting gay and bisexual men from donating to sperm banks in Canada, CTV News has learned. The federal health agency has adopted a revised directive removing the ban on gay, bisexual and other men who have sex with men, effective May 8.
Colin Jost names one celebrity who is great at hosting 'Saturday Night Live'
Colin Jost, who co-anchors Saturday Night Live's 'Weekend Update,' revealed who he thinks is one of the best hosts on the show.
Sports columnist apologizes for 'oafish' comments directed at Caitlin Clark. The controversy isn't over
A male columnist has apologized for a cringeworthy moment during former University of Iowa superstar and college basketball's highest scorer Caitlin Clark's first news conference as an Indiana Fever player.
'Shopaholic' author Sophie Kinsella reveals brain cancer diagnosis
Sophie Kinsella, the best-selling author behind the 'Shopaholic' book series, has revealed that she is receiving treatment for brain cancer.